1. The European Parliament and of The Council, Regulation (EC) No 141/2000 of The European Parliament and of The Council of 16 December 1999 on orphan medicinal products. 2000.
2. Access to orphan drugs in the Middle East: Challenge and perspective;Z.S. Almalki;Intractable Rare Dis Res,2012
3. Quality of life in rare genetic conditions: a systematic review of the literature;J.S. Cohen;American journal of medical genetics. Part A,2010
4. Kaplan, W., et al., Priority medicines for Europe and the world—2013 update. 2013, WHO Library.